Clinical trials: Primary Insomnia
Sleep Initiation and Maintenance Disorders
Efficacy Study of LY2422347 to Treat Insomnia
The purpose of this study is to determine whether a compound known as LY2422347 is effective in treating people diagnosed with primary insomnia (difficulty sleeping with no other significant contributing factor, such as…
- Trial name
- NCT00259311
- Testing
- LY2422347
- Where
- 22 sites in United States
- Volunteers
- 400 people
- Sponsor
- Eli Lilly and Company
Primary Insomnia
The Psychoneuroimmunology of Insomnia
Chronic insomnia affects approximately 8-9% of the population. The prevalence of this disorder rises dramatically across the lifespan, especially so in women.
- Trial name
- NCT00680771
- Where
- United States
- Volunteers
- 28 people, healthy volunteers welcome
- Sponsor
- University of Rochester
Insomnia, Primary
Effects of Zero-Time Exercise (ZTEx) on Inactive Adults With Insomnia Disorder
This randomized controlled trial (RCT) with a longitudinal mixed-method process evaluation aims to (1) determine the effectiveness of a ZTEx intervention program, which is a lifestyle-integrated physical activity program, on…
- Trial name
- NCT04227587
- Testing
- Zero Time Exercise, Sleep hygiene education
- Where
- Hong Kong
- Volunteers
- 140 people
- Sponsor
- The Hong Kong Polytechnic University
Primary Insomnia
Efficacy and Safety of 5 mg Sublingual Zolpidem vs 10mg Oral Zolpidem in the Induction and Maintenance of Sleep in Patients With Primary Insomnia
The purpose of this study is to evaluate the efficacy and safety of sublingual zolpidem presentation 5 mg in the induction of sleep in patients with primary insomnia.
- Trial name
- NCT01896336
- Testing
- Zolpidem Hemitartrate
- Where
- Brazil
- Volunteers
- 67 people
- Sponsor
- EMS
Primary Insomnia
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)
The purpose of this study is determine whether this drug will improve your insomnia in terms of decreasing your time to fall asleep and allowing you to stay asleep longer.
- Trial name
- NCT00420810
- Testing
- MK0928 / Duration of Treatment : 8 Weeks
- Volunteers
- 138 people
- Sponsor
- H. Lundbeck A/S
Sleep Initiation and Maintenance Disorders, Insomnia
Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year
The purpose of the study is to assess efficacy and safety of eplivanserin in the population of patients complaining of sleep maintenance insomnia.
- Trial name
- EPLILONG (NCT00253903)
- Testing
- eplivanserin (SR46349)
- Where
- 14 sites in United States, Argentina and 12 more
- Volunteers
- 1,155 people
- Sponsor
- Sanofi
Insomnia, Night Wakings
Infant Night Wakings in Pediatric Primary Care
This study aims to: 1. identify which single item or combination of two items perform best in identifying problematic infant night wakings and 2.
- Trial name
- NCT02780596
- Testing
- Item1, Item2, Item3
- Where
- United States
- Volunteers
- 3,501 people
- Sponsor
- Indiana University
Insomnia Disorders, Insomnia Disorder
Comparative Efficacy of BRT and CBT-I for Insomnia
This study evaluates two behavioral treatments for patients with insomnia disorder: Bedtime Restriction Therapy (BRT) and Cognitive Behavioral Therapy for Insomnia (CBT-I).
- Conditions
- Insomnia Disorders, Insomnia Disorder, Insomnia, Insomnia Chronic
- Trial name
- SLEEPwindow (NCT06767137)
- Testing
- Cognitive behavioral therapy for insomnia (CBT-I), Bedtime restriction (BRT)
- Where
- 2 sites in Switzerland
- Volunteers
- 160 people
- Sponsor
- Christoph Nissen
Insomnia, Insomnia (Moderate)
ASV Therapy for Insomnia
This will be a single center, prospective study designed to evaluate the effect of adaptive servo ventilation therapy on insomnia severity among patients with moderate to severe chronic insomnia.
- Trial name
- NCT07011966
- Testing
- ASV therapy
- Where
- United States
- Volunteers
- 25 people
- Sponsor
- ResMed
Primary Insomnia
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028)
This is a multicenter study to test the hypothesis that suvorexant (MK-4305) is superior to placebo in improving insomnia as measured by change from baseline in: subjective total sleep time and time to sleep onset, wake time…
- Trial name
- NCT01097616
- Testing
- Suvorexant High Dose (HD), Suvorexant Low Dose (LD)
- Volunteers
- 1,023 people
- Sponsor
- Merck Sharp & Dohme LLC
Primary Insomnia
Efficacy and Safety of Eplivanserin 5mg/Day in Insomnia Characterized by Sleep Maintenance Difficulties
Primary objective: To assess the efficacy of eplivanserin 5mg/day in comparison to placebo after 6 weeks of treatment on sleep maintenance of insomniac patients, as measured by Polysomnography Wake Time After Sleep Onset…
- Trial name
- ECLIPSE (NCT00805350)
- Testing
- Eplivanserin
- Where
- 7 sites in United States, Austria and 5 more
- Volunteers
- 637 people
- Sponsor
- Sanofi
Primary Insomnia
A Study of Gaboxadol in Primary Insomnia
To evaluate the safety and tolerability of gaboxadol in primary insomnia.
- Trial name
- NCT00209963
- Testing
- Gaboxadol
- Volunteers
- 600 people
- Sponsor
- H. Lundbeck A/S
Insomnia
A Treatment Study Comparing Two Non-Drug, Self-Help Treatment of Chronic Insomnia.
The purpose of this study is to determine whether a handheld computer is superior to a self-help manual for the treatment of chronic primary insomnia.
- Trial name
- NCT00310284
- Testing
- Computerized delivery of cognitive-behavioral treatment of insomnia, Self-help manual to improve insomnia symptoms
- Where
- United States
- Volunteers
- 200 people, healthy volunteers welcome
- Sponsor
- PICS, Inc.
Insomnia, Primary, Depression
Sleep to Prevent Evolving Affecting Disorders
The primary objective of the proposed research is to determine the efficacy of Digital Cognitive Behavior Therapy (dCBTI) in reducing severity of depression and also in preventing the incidence and relapse of depression among…
- Trial name
- SPREAD (NCT02988375)
- Testing
- dCBTI, Sleep Education
- Where
- United States
- Volunteers
- 1,385 people
- Sponsor
- Henry Ford Health System
Primary Insomnia
Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)
A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.
- Trial name
- NCT00266357
- Testing
- MK0928, gaboxadol / Duration of Treatment: 6 days for treatment periods (2 days/dose)
- Volunteers
- 50 people
- Sponsor
- H. Lundbeck A/S
Sleep Initiation and Maintenance Disorders
A Comparison of the Therapeutic Effect Between Head-point Acupuncture and Conventional Body Acupuncture on Insomnia
The investigators will conduct a single-center, and randomized controlled cases study. A total of 120 participants with insomnia will be enrolled.
- Trial name
- NCT04405427
- Testing
- head acupoints acupuncture, body acupoints acupuncture
- Where
- Taiwan
- Volunteers
- 120 people
- Sponsor
- Chang Gung Memorial Hospital
Primary Insomnia
Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029)
This is a multicenter study to test the hypothesis that suvorexant (MK-4305) is superior to placebo in improving insomnia as measured by change from baseline in: subjective total sleep time and time to sleep onset, wake time…
- Trial name
- NCT01097629
- Testing
- Suvorexant High Dose (HD), Suvorexant Low Dose (LD)
- Volunteers
- 1,020 people
- Sponsor
- Merck Sharp & Dohme LLC
Primary Insomnia
Polysomnography Study of MK-6096 in Participants With Primary Insomnia (MK-6096-011)
This was a cross-over, polysomnography (PSG) study to test the safety, tolerability and effectiveness of different doses of MK-6096 in the treatment of participants with primary insomnia.
- Trial name
- NCT01021852
- Testing
- MK-6096
- Volunteers
- 326 people
- Sponsor
- Merck Sharp & Dohme LLC
Insomnia, Migraine Disorders
Intervention for Sleep and Pain in Youth: A Randomized Controlled Trial
Insomnia is a common comorbidity among adolescents with migraine. This randomized controlled clinical trial aims to determine efficacy of cognitive-behavioral therapy (CBT) for insomnia, as well as the combined effect of CBT…
- Conditions
- Insomnia, Migraine Disorders, Headache Disorders
- Trial name
- I-SPY-RCT (NCT04936321)
- Testing
- Internet-delivered CBT for Insomnia, Internet-delivered CBT for Pain Management, Internet-delivered Sleep Education
- Where
- United States
- Volunteers
- 224 people
- Sponsor
- Seattle Children's Hospital
Caregivers
Cereset Research for Caregivers
Caregivers experience high levels of prolonged stress that can lead to chronic problems with health, including increased risk of cardiovascular disease that is linked to autonomic dysregulation.
- Trial name
- NCT05209438
- Testing
- Cereset Research
- Where
- United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- Wake Forest University Health Sciences